Details for New Drug Application (NDA): 010010
✉ Email this page to a colleague
NDA 010010 describes STILPHOSTROL, which is a drug marketed by Bayer Pharms and is included in one NDA. Additional details are available on the STILPHOSTROL profile page.
The generic ingredient in STILPHOSTROL is diethylstilbestrol diphosphate. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol diphosphate profile page.
The generic ingredient in STILPHOSTROL is diethylstilbestrol diphosphate. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol diphosphate profile page.
Summary for 010010
| Tradename: | STILPHOSTROL |
| Applicant: | Bayer Pharms |
| Ingredient: | diethylstilbestrol diphosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 250MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
